TY - GEN
T1 - Relation between left atrial pressure and the corresponding pulse pressure in the helical flow total artificial heart
AU - Wu, Sheng Yuan
AU - Saito, Itsuro
AU - Isoyama, Takashi
AU - Inoue, Yusuke
AU - Ishii, Kohei
AU - Sato, Masami
AU - Hara, Shintaro
AU - Hosoda, Kyohei
AU - Ariyoshi, Koki
AU - Li, Xinyang
AU - Nakagawa, Hidemoto
AU - Ono, Toshiya
AU - Abe, Yusuke
PY - 2013/10/31
Y1 - 2013/10/31
N2 - The present control method used in our helical flow total artificial heart (HFTAH) would only need four parameters. Nowadays, gauge pressure sensors are being used to obtain the pressure needed for control parameters. Nevertheless, there are also many following problems such as calibration, maintenance, offset drift and infection due to the skin-penetrative lines for the usage of gauge pressure sensor. Therefore, it is preferable to find another substitutional way instead of the gauge sensor to measure the pressure. In addition, with an eye to completing an implantable HFTAH, we would like to do without any lines through the experiment animal. Therefore, it was confirmed in this study that whether there is a relation between the left atrial pressure (LAP) and its pulse pressure (amplitude). Subsequently the mean value of LAP and its amplitude were quantified. There are two methods used in this study to process the data. Method one, frequency spectrum analysis, is to quantify the signals by getting the absolute value of amplitude for a fixed heartbeat analysis. Method two, by using the synchronous detection method, it is postulated to be more applicable to variant heartbeat data with 1/R control. By the relation of LAP and the pulse pressure acquired in the above two methods, as long as the amplitude of LAP is known by the absolute pressure sensor, it's able to obtain the mean value of LAP (for it suggests a linear relation). Therefore the characteristic could substitute one of the control parameter (that is the LAP), and the other three parameters will be acquired by estimation thus it doesn't need to measure them additionally. Consequently, it is expected that acquiring LAP by absolute pressure sensor for one of the control parameters could attain to an implantable HFTAH.
AB - The present control method used in our helical flow total artificial heart (HFTAH) would only need four parameters. Nowadays, gauge pressure sensors are being used to obtain the pressure needed for control parameters. Nevertheless, there are also many following problems such as calibration, maintenance, offset drift and infection due to the skin-penetrative lines for the usage of gauge pressure sensor. Therefore, it is preferable to find another substitutional way instead of the gauge sensor to measure the pressure. In addition, with an eye to completing an implantable HFTAH, we would like to do without any lines through the experiment animal. Therefore, it was confirmed in this study that whether there is a relation between the left atrial pressure (LAP) and its pulse pressure (amplitude). Subsequently the mean value of LAP and its amplitude were quantified. There are two methods used in this study to process the data. Method one, frequency spectrum analysis, is to quantify the signals by getting the absolute value of amplitude for a fixed heartbeat analysis. Method two, by using the synchronous detection method, it is postulated to be more applicable to variant heartbeat data with 1/R control. By the relation of LAP and the pulse pressure acquired in the above two methods, as long as the amplitude of LAP is known by the absolute pressure sensor, it's able to obtain the mean value of LAP (for it suggests a linear relation). Therefore the characteristic could substitute one of the control parameter (that is the LAP), and the other three parameters will be acquired by estimation thus it doesn't need to measure them additionally. Consequently, it is expected that acquiring LAP by absolute pressure sensor for one of the control parameters could attain to an implantable HFTAH.
UR - http://www.scopus.com/inward/record.url?scp=84886448469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886448469&partnerID=8YFLogxK
U2 - 10.1109/EMBC.2013.6609589
DO - 10.1109/EMBC.2013.6609589
M3 - Conference contribution
C2 - 24109776
AN - SCOPUS:84886448469
SN - 9781457702167
T3 - Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
SP - 671
EP - 674
BT - 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013
T2 - 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013
Y2 - 3 July 2013 through 7 July 2013
ER -